{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T20:16:45Z","timestamp":1767817005336,"version":"3.49.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>\n                    A 65-year-old man with systemic mastocytosis and associated hematological neoplasm (plasma cell myeloma, SM-AHN) received an\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT for staging. In addition to the typical bone marrow and splenic uptake, PET\/CT also showed diffuse\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG uptake in the gastric wall. It suggested the involvement of myeloma or mastocytosis. Subsequent histopathologic analysis of gastric biopsy specimens through endoscopy confirmed the diagnosis of mastocytosis involvement.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006134","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T14:00:23Z","timestamp":1757685623000},"page":"171-172","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diffuse Gastric Uptake on 18F-FDG PET\/CT Caused by Involvement of Mastocytosis in a Patient With Systemic Mastocytosis"],"prefix":"10.1097","volume":"51","author":[{"given":"Yu","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu"},{"name":"Department of Nuclear Medicine, The Second People\u2019s Hospital of Yibin, Yibin, Sichuan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second People\u2019s Hospital of Yibin, Yibin, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minggang","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5277-074X","authenticated-orcid":false,"given":"Chengzhong","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"R1-20260107","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1182\/blood-2017-12-824318","article-title":"Systemic mastocytosis with concurrent multiple myeloma","volume":"131","author":"Prabahran","year":"2018","journal-title":"Blood"},{"key":"R2-20260107","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.semnuclmed.2014.08.002","article-title":"Multiple myeloma: 18F-FDG-PET\/CT and diagnostic imaging","volume":"45","author":"Mihailovic","year":"2015","journal-title":"Semin Nucl Med"},{"key":"R3-20260107","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00259-015-3117-3","article-title":"FDG-PET\/CT findings in systemic mastocytosis: a French multicentre study","volume":"42","author":"Djelbani-Ahmed","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-20260107","first-page":"2048","article-title":"Systemic mastocytosis: current status and challenges in 2024","volume":"9","author":"Ustun","year":"2025","journal-title":"Blood Adv"},{"key":"R5-20260107","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/14728214.2023.2221028","article-title":"Systemic mastocytosis: 2023 update on diagnosis and management in adults","volume":"28","author":"Costa","year":"2023","journal-title":"Expert Opin Emerg Drugs"},{"key":"R6-20260107","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1097\/RLU.0000000000003817","article-title":"CXCR4 Expression demonstrated by 68Ga-Pentixafor PET\/CT imaging in a case of systemic mastocytosis mimicking lymphoma","volume":"46","author":"Kiran","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R7-20260107","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"R8-20260107","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s00259-007-0477-3","article-title":"An analysis of the physiological FDG uptake in the stomach with the water gastric distention method","volume":"34","author":"Kamimura","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-20260107","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12880-016-0161-9","article-title":"(18)F-FDG uptake in the stomach on screening PET\/CT: value for predicting Helicobacter pylori infection and chronic atrophic gastritis","volume":"16","author":"Kobayashi","year":"2016","journal-title":"BMC Med Imaging"},{"key":"R10-20260107","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1097\/RLU.0000000000001133","article-title":"FDG PET\/CT findings of M\u00e9n\u00e9trier disease","volume":"41","author":"Dong","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R11-20260107","doi-asserted-by":"crossref","first-page":"e864","DOI":"10.1097\/MD.0000000000000864","article-title":"18F-FDG PET\/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography","volume":"94","author":"Altini","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R12-20260107","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12149-013-0791-8","article-title":"Metabolic information on staging FDG-PET-CT as a prognostic tool in the evaluation of 97 patients with gastric cancer","volume":"28","author":"Coupe","year":"2014","journal-title":"Ann Nucl Med"},{"key":"R13-20260107","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T19:00:26Z","timestamp":1767812426000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006134","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"2025-07-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}